公开(公告)号：US20040022922A1

公开(公告)日：2004-02-05

申请号：US10275748

申请日：2002-11-08

Inventor： David Rutenberg

IPC: A23D007/00

CPC classification number: A23J7/00 ,  A23L33/40 ,  A23V2002/00 ,  A23V2250/1844 ,  A23V2250/1852 ,  A23V2250/1846 ,  A23V2250/1848 ,  A23V2250/185

Abstract: The present invention relates to pharmaceutical or nutritional or food composition for feeding infants which is more similar to human milk in a powder or fluid form, having an effect of addressing the shortcomings of the presently known infant formulas by the inclusion of a phospholipid supplement which contains at least 1% (w/w) phosphatidyserine out of the total phospholipid content of the composition wherein the phosphatidylserine has a structural fatty acid chain derived from at least one raw material lecithin selected from the group consisting of soy bean lecithin, rapeseed lecithin, or egg yolk lecithin, and which is produced by reaction pith phospholipase-D.

公开(公告)号：US06515020B1

公开(公告)日：2003-02-04

申请号：US09806454

申请日：2001-03-30

Applicant: Claudio Cavazza

Inventor： Claudio Cavazza

IPC: A61K31225

CPC classification number: A61K31/205 ,  A23L33/10 ,  A23L33/105 ,  A23L33/15 ,  A23V2002/00 ,  Y10S514/822 ,  A61K31/03 ,  A61K2300/00 ,  A23V2250/0612 ,  A23V2250/21 ,  A23V2250/1846 ,  A23V2250/1852 ,  A23V2250/712 ,  A23V2250/1626 ,  A23V2250/161 ,  A23V2250/708 ,  A23V2250/211 ,  A23V2250/2132 ,  A23V2250/704 ,  A23V2250/0642 ,  A23V2250/0606 ,  A23V2250/063

Abstract: A pharmaceutical product which comprises admixed or separately packaged (A) L-Carnitine or an alkanoyl L-canitine and (B) a trihydroxy- or tetrahydroxystilbene such as resveratrol is useful for the prevention and treatment of pathological neuronal or cerebral disorders.

Abstract translation: 包含混合或单独包装的（A）L-肉毒碱或烷酰基L-缬氨酸和（B）三羟基 - 或四氢芪烯如白藜芦醇的药物产品可用于预防和治疗病理性神经元或脑部疾病。

公开(公告)号：US10039734B2

公开(公告)日：2018-08-07

申请号：US15493148

申请日：2017-04-21

Applicant: Qualitas Health, Ltd.

Inventor： Brian J. Waibel ,  Hans Schonemann ,  Val Krukonis ,  Michael Kagan

IPC: A61K31/202 ,  C07H15/06 ,  A23L33/12 ,  C12P7/64 ,  C11B3/00

CPC classification number: A61K31/202 ,  A23L33/12 ,  A23V2002/00 ,  C07H15/06 ,  C11B3/006 ,  C12P7/6427 ,  A23V2250/1846 ,  A23V2250/185 ,  A23V2250/187 ,  A23V2250/2136

Abstract: Provided herein are compositions comprising eicosapentaenoic acid (EPA) and polar lipids (e.g., glycolipids and phospholipids), and which do not contain any docosahexaenoic acid (DHA) or esterified fatty acids.

公开(公告)号：US20170216322A1

公开(公告)日：2017-08-03

申请号：US15260217

申请日：2016-09-08

Applicant: Neptune Technologies & Bioressources, Inc.

Inventor： Fotini Sampalis

IPC: A61K31/661 ,  A61K31/122 ,  A23L33/00 ,  A61K35/612 ,  A23J7/00 ,  A23L33/115 ,  A61K9/48 ,  A61K9/00

CPC classification number: A61K31/661 ,  A23J7/00 ,  A23K20/158 ,  A23L33/115 ,  A23L33/30 ,  A23V2002/00 ,  A61K8/553 ,  A61K9/0053 ,  A61K9/48 ,  A61K31/122 ,  A61K31/353 ,  A61K31/6615 ,  A61K31/683 ,  A61K31/685 ,  A61K35/612 ,  A61K2800/522 ,  A61Q19/00 ,  C07D407/14 ,  C07F9/10 ,  C07F9/117 ,  C11B1/10 ,  Y10S514/824 ,  A23V2250/1846 ,  A23V2250/1852 ,  A23V2250/1848 ,  A23V2250/185 ,  A23V2250/1868 ,  A23V2250/187 ,  A23V2250/70

Abstract: A phospholipid extract from a marine or aquatic biomass possesses therapeutic properties. The phospholipid extract comprises a variety of phospholipids, fatty acid, metals and a novel flavonoid.

公开(公告)号：US09585900B2

公开(公告)日：2017-03-07

申请号：US14755154

申请日：2015-06-30

Applicant: N. V. Nutricia

Inventor： Mattheus Cornelis De Wilde ,  Robert Johan Joseph Hageman ,  Martine Groenendijk ,  Patrick Joseph Gerardus Hendrikus Kamphuis

IPC: A01N43/04 ,  A61K31/70 ,  A61K31/675 ,  A61K31/14 ,  A61K31/202 ,  A61K31/355 ,  A61K31/375 ,  A61K31/4415 ,  A61K31/519 ,  A61K31/683 ,  A61K31/685 ,  A61K31/7072 ,  A61K31/714 ,  A61K33/04 ,  A61K45/06 ,  A61K31/20 ,  A61K31/661 ,  A61K31/7056 ,  A61K31/7068 ,  C07H19/06 ,  C07H19/052

CPC classification number: A61K31/675 ,  A23L33/12 ,  A23L33/13 ,  A23L33/15 ,  A23L33/40 ,  A23V2002/00 ,  A61K31/14 ,  A61K31/20 ,  A61K31/202 ,  A61K31/355 ,  A61K31/375 ,  A61K31/4415 ,  A61K31/519 ,  A61K31/661 ,  A61K31/683 ,  A61K31/685 ,  A61K31/70 ,  A61K31/7056 ,  A61K31/7068 ,  A61K31/7072 ,  A61K31/714 ,  A61K33/04 ,  A61K45/06 ,  C07H19/052 ,  C07H19/06 ,  A61K2300/00 ,  A23V2200/316 ,  A23V2200/322 ,  A23V2250/1882 ,  A23V2250/304 ,  A23V2250/704 ,  A23V2250/156 ,  A23V2250/1626 ,  A23V2250/1844 ,  A23V2250/1846 ,  A23V2250/1848 ,  A23V2250/185 ,  A23V2250/1852 ,  A23V2250/1868 ,  A23V2250/187 ,  A23V2250/5424 ,  A23V2250/7052 ,  A23V2250/7058 ,  A23V2250/706 ,  A23V2250/308

Abstract: Non-medical use of at least two components selected from the group of: (i) nucleoside equivalents, (ii) n-3 polyunsaturated fatty acids selected from the group of DHA, DPA and EPA, (iii) vitamins B, (iv) phospholipids, (v) antioxidants and (vi) cholines—with the proviso that at least one (i) nucleoside or at least one (iii) vitamin B is present—for increasing or maintaining the body weight, for improving the ability to perform an activity of daily living of a mammal, for maintaining the ability to perform an activity of daily living of a mammal, or for reducing a deterioration in the ability to perform an activity of daily living of a mammal.

Abstract translation: 至少两种选自下组的组分的非医疗用途：（i）核苷当量，（ii）选自DHA，DPA和EPA的n-3多不饱和脂肪酸，（iii）维生素B，（iv） 磷脂，（v）抗氧化剂和（vi）胆碱 - 条件是存在至少一种（i）核苷或至少一种（iii）维生素B），用于增加或维持体重，以提高执行 哺乳动物的日常生活活动，维持哺乳动物日常生活活动的能力，或降低进行哺乳动物日常生活活动能力的劣化。

公开(公告)号：US20170028032A1

公开(公告)日：2017-02-02

申请号：US15302519

申请日：2015-04-06

Applicant: SUNTORY HOLDINGS LIMITED

Inventor： Nozomi KITAHARA ,  Megumi OKADA

IPC: A61K38/39 ,  A23L27/00 ,  A23L33/18 ,  A61K47/24 ,  A61K9/00

CPC classification number: A61K38/39 ,  A23L27/84 ,  A23L27/86 ,  A23L29/10 ,  A23L33/17 ,  A23L33/18 ,  A23V2002/00 ,  A61K9/0053 ,  A61K9/0095 ,  A61K9/2013 ,  A61K47/24 ,  A23V2200/16 ,  A23V2250/1846 ,  A23V2250/1848 ,  A23V2250/185 ,  A23V2250/1852 ,  A23V2250/55

Abstract: An object of the present invention is to provide a technique for masking the bitterness of collagen peptide containing compositions.By incorporating glycerophospholipids comprising neutral glycerophospholipids and acidic glycerophospholipids in specified proportions or incorporating sphingoglycolipids in a specified proportion relative to collagen peptides, there can be provided methods for masking the bitterness of collagen peptide containing compositions.

Abstract translation: 通过以规定的比例并入包含中性甘油磷脂和酸性甘油磷脂的甘油磷脂，相对于胶原肽以规定的比例掺入鞘糖脂，可以提供掩蔽含有胶原肽的组合物的苦味的方法。

公开(公告)号：US20150335716A1

公开(公告)日：2015-11-26

申请号：US14815841

申请日：2015-07-31

Applicant: Allergy Research Group, LLC

Inventor： Robert A. Settineri

IPC: A61K38/28 ,  A61K31/122 ,  A61K31/685 ,  A61K31/661 ,  A61K31/683 ,  A61K31/7028 ,  A61K31/593 ,  A61K31/375 ,  A61K38/44 ,  A61K31/385 ,  A61K36/31 ,  A61K36/81 ,  A61K36/23 ,  A61K36/21 ,  A61K36/88 ,  A61K36/48 ,  A61K31/05 ,  A61K36/45 ,  A61K36/73 ,  A61K36/736 ,  A61K36/87 ,  A61K33/22 ,  A23L1/00 ,  A23L1/30 ,  A61K9/00

CPC classification number: A61K31/522 ,  A23D9/013 ,  A23L29/10 ,  A23L29/244 ,  A23L33/105 ,  A23L33/115 ,  A23L33/12 ,  A23V2002/00 ,  A61K9/0056 ,  A61K31/05 ,  A61K31/122 ,  A61K31/16 ,  A61K31/375 ,  A61K31/385 ,  A61K31/593 ,  A61K31/66 ,  A61K31/661 ,  A61K31/683 ,  A61K31/685 ,  A61K31/7028 ,  A61K31/716 ,  A61K31/733 ,  A61K33/22 ,  A61K36/21 ,  A61K36/23 ,  A61K36/31 ,  A61K36/45 ,  A61K36/48 ,  A61K36/73 ,  A61K36/736 ,  A61K36/81 ,  A61K36/87 ,  A61K36/88 ,  A61K38/28 ,  A61K38/44 ,  A61K38/446 ,  A61K45/06 ,  A61K47/02 ,  A61K47/10 ,  A61K47/12 ,  A61K47/46 ,  C12Y111/01006 ,  C12Y115/01001 ,  A61K2300/00 ,  A23V2200/302 ,  A23V2200/316 ,  A23V2200/33 ,  A23V2250/184 ,  A23V2200/30 ,  A23V2250/1844 ,  A23V2250/1846 ,  A23V2250/1848 ,  A23V2250/185 ,  A23V2250/1852 ,  A23V2250/314 ,  A23V2250/5062 ,  A23V2250/7106 ,  A23V2250/714 ,  A23V2250/026 ,  A23V2250/708 ,  A23V2250/21

Abstract: Flavored chewable wafers containing nutritional supplement formulations suitable for enhancement of cell and mitochondrial function as well as providing antioxidants and aiding in weight loss and other desirable nutritional benefits comprises enriched formulations of phospholipids, specifically identified concentrations of phosphatidylglycerol, phosphatidic acid, phosphatidylethanolamine, phosphatidylcholine, glycolipids and phosphatidylserine along with inulin and other desirable active ingredients. These edible wafer lipid combinations can be used to treat mitochondrial disorders and other nutritional deficiencies associated with medical pathologies, chronic illnesses and syndromes, or to maintain lipid balance for normal mitochondrial function, and can be administered in pleasant tasting chewable wafers.

Abstract translation: 包含适合于增强细胞和线粒体功能以及提供抗氧化剂和辅助减肥和其它所需营养益处的营养补充剂制剂的调味咀嚼片包括磷脂的富集配方，特别确定浓度的磷脂酰甘油，磷脂酸，磷脂酰乙醇胺，磷脂酰胆碱，糖脂 和磷脂酰丝氨酸以及菊粉和其他所需的活性成分。 这些可食用的晶片脂质组合可用于治疗与医学病理学，慢性疾病和综合征相关的线粒体病症和其他营养缺陷，或维持正常线粒体功能的脂质平衡，并且可以在宜人的品尝咀嚼的晶片中施用。

公开(公告)号：US08680080B2

公开(公告)日：2014-03-25

申请号：US13280182

申请日：2011-10-24

Applicant: Fotini Sampalis

Inventor： Fotini Sampalis

IPC: A61K31/683 ,  A61K31/215

CPC classification number: A61K31/661 ,  A23J7/00 ,  A23K20/158 ,  A23L33/115 ,  A23L33/30 ,  A23V2002/00 ,  A61K8/553 ,  A61K9/0053 ,  A61K9/48 ,  A61K31/122 ,  A61K31/353 ,  A61K31/6615 ,  A61K31/683 ,  A61K31/685 ,  A61K35/612 ,  A61K2800/522 ,  A61Q19/00 ,  C07D407/14 ,  C07F9/10 ,  C07F9/117 ,  C11B1/10 ,  Y10S514/824 ,  A23V2250/1846 ,  A23V2250/1852 ,  A23V2250/1848 ,  A23V2250/185 ,  A23V2250/1868 ,  A23V2250/187 ,  A23V2250/70

Abstract: A phospholipid extract from a marine or aquatic biomass possesses therapeutic properties. The phospholipid extract comprises a variety of phospholipids, fatty acid, metals and a novel flavonoid.

Abstract translation: 来自海洋或水生生物的磷脂提取物具有治疗性质。 磷脂提取物包含多种磷脂，脂肪酸，金属和新颖的类黄酮。

公开(公告)号：US20130331352A1

公开(公告)日：2013-12-12

申请号：US13977168

申请日：2011-12-28

Applicant: Robert Johan Joseph Hageman ,  Mattheus Cornelis De Wilde ,  Martine Groenendijk ,  Patrick Joseph Gerardus Hendrikus Kamphuis

Inventor： Robert Johan Joseph Hageman ,  Mattheus Cornelis De Wilde ,  Martine Groenendijk ,  Patrick Joseph Gerardus Hendrikus Kamphuis

IPC: A61K31/7072 ,  A61K31/20 ,  A61K31/14 ,  A61K31/7056 ,  A61K31/661

CPC classification number: A61K31/675 ,  A23L33/12 ,  A23L33/13 ,  A23L33/15 ,  A23L33/40 ,  A23V2002/00 ,  A61K31/14 ,  A61K31/20 ,  A61K31/202 ,  A61K31/355 ,  A61K31/375 ,  A61K31/4415 ,  A61K31/519 ,  A61K31/661 ,  A61K31/683 ,  A61K31/685 ,  A61K31/70 ,  A61K31/7056 ,  A61K31/7068 ,  A61K31/7072 ,  A61K31/714 ,  A61K33/04 ,  A61K45/06 ,  A61P25/28 ,  C07H19/052 ,  C07H19/06 ,  A61K2300/00 ,  A23V2200/316 ,  A23V2200/322 ,  A23V2250/1882 ,  A23V2250/304 ,  A23V2250/704 ,  A23V2250/156 ,  A23V2250/1626 ,  A23V2250/1844 ,  A23V2250/1846 ,  A23V2250/1848 ,  A23V2250/185 ,  A23V2250/1852 ,  A23V2250/1868 ,  A23V2250/187 ,  A23V2250/5424 ,  A23V2250/7052 ,  A23V2250/7058 ,  A23V2250/706 ,  A23V2250/308

Abstract: Composition comprising at least two components, more preferably at least three components, more preferably at least four components, selected from the group of (i) a nucleoside equivalent, (ii) an ω-3 polyunsaturated fatty acid selected from the group of DHA, DPA and EPA, (iii) a vitamin B, (iv) a phospholipid, (v) an antioxidant and (vi) a choline, with the proviso that at least component (i) or (iii) is present, for use in the prevention or treatment of frailty in a mammal, wherein frailty is determined by compliance with at least 2 criterions, preferably 3 criterions, selected from the group of muscle weakness, excessive feelings of exhaustion or fatigue, abnormally low physical activity, slow or unsteady gait, weight loss, and neurological dysfunction.

Abstract translation: 组合物，其包含至少两种组分，更优选至少三种组分，更优选至少四种组分，其选自（i）核苷当量，（ii）选自DHA的ω-3多不饱和脂肪酸， DPA和EPA，（iii）维生素B，（iv）磷脂，（v）抗氧化剂和（vi）胆碱，条件是存在至少组分（i）或（iii），用于 预防或治疗哺乳动物的虚弱，其中通过符合从肌肉无力，疲劳或疲劳过度感觉，异常低体力活动，慢或不稳定步态组中选择的至少2个标准，优选3个标准来确定虚弱， 体重减轻和神经功能障碍。

公开(公告)号：US20130202689A1

公开(公告)日：2013-08-08

申请号：US13750663

申请日：2013-01-25

Applicant: NEPTUNE TECHNOLOGIES & BIORESSOURCES, Inc.

Inventor： Fotini Sampalis

IPC: A61K31/6615 ,  A61K31/353 ,  C07F9/117 ,  C07F9/10

CPC classification number: A61K31/661 ,  A23J7/00 ,  A23K20/158 ,  A23L33/115 ,  A23L33/30 ,  A23V2002/00 ,  A61K8/553 ,  A61K9/0053 ,  A61K9/48 ,  A61K31/122 ,  A61K31/353 ,  A61K31/6615 ,  A61K31/683 ,  A61K31/685 ,  A61K35/612 ,  A61K2800/522 ,  A61Q19/00 ,  C07D407/14 ,  C07F9/10 ,  C07F9/117 ,  C11B1/10 ,  Y10S514/824 ,  A23V2250/1846 ,  A23V2250/1852 ,  A23V2250/1848 ,  A23V2250/185 ,  A23V2250/1868 ,  A23V2250/187 ,  A23V2250/70

Abstract: A phospholipid extract from a marine or aquatic biomass possesses therapeutic properties. The phospholipid extract comprises a variety of phospholipids, fatty acid, metals and a novel flavonoid.